[HTML][HTML] Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
[PDF][PDF] Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
L Keller, Y Belloum, H Wikman, K Pantel - 2020 - scholar.archive.org
BACKGROUND Cell-free DNA (cfDNA) refers to extracellular DNA molecules (double-
stranded DNA and mitochondrial DNA) originating from any cell type found in body fluids …
stranded DNA and mitochondrial DNA) originating from any cell type found in body fluids …
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
L Keller, Y Belloum, H Wikman… - British journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
L Keller, Y Belloum, H Wikman, K Pantel - British Journal of Cancer, 2021 - hero.epa.gov
Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
L Keller, Y Belloum, H Wikman, K Pantel - British Journal of Cancer, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Cell-free DNA (cfDNA) derived from tumours is
present in the plasma of cancer patients. The majority of currently available studies on the …
present in the plasma of cancer patients. The majority of currently available studies on the …
[HTML][HTML] Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
L Keller, Y Belloum, H Wikman, K Pantel - British Journal of Cancer, 2021 - ncbi.nlm.nih.gov
Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond.
L Keller, Y Belloum, H Wikman, K Pantel - British Journal of Cancer, 2020 - europepmc.org
Cell-free DNA (cfDNA) derived from tumours is present in the plasma of cancer patients. The
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …
majority of currently available studies on the use of this circulating tumour DNA (ctDNA) deal …